Rosenthal T, Holtzman E, Segal P
Atherosclerosis. 1980 May;36(1):111-5. doi: 10.1016/0021-9150(80)90204-x.
The effect of chlorthalidone treatment on serum lipids and lipoproteins was investigated in 21 hypertensive patients. Chlorthalidone caused an increase in total serum and low density lipoprotein (LDL) cholesterol, but not in high density lipoprotein (HDL) cholesterol. Serum and lipoprotein triglycerides also increased. Our findings suggest that chlorthalidone increases serum concentrations of "atherogenic" lipoproteins (LDL and VLDL), and possibly decreases the levels of a "beneficial" lipoprotein, namely HDL. Thus, the use of this medication may increase a major atherosclerosis risk factor.
在21例高血压患者中研究了氯噻酮治疗对血脂和脂蛋白的影响。氯噻酮导致血清总胆固醇和低密度脂蛋白(LDL)胆固醇升高,但高密度脂蛋白(HDL)胆固醇未升高。血清和脂蛋白甘油三酯也升高。我们的研究结果表明,氯噻酮会增加“致动脉粥样硬化”脂蛋白(LDL和VLDL)的血清浓度,并可能降低一种“有益”脂蛋白即HDL的水平。因此,使用这种药物可能会增加一个主要的动脉粥样硬化危险因素。